‚Äč

FREE COMMUNICATION 7

 

15:15 - 16:45   HALL C

 

Free Communication Session 7

 

Anaemia management

 

Chairs: Adrian Covic, Iasi, Romania

            Iain C. Macdougall, London, United Kingdom

 

FREE COMMUNICATIONS

 

SO033

INTERIM ANALYSIS RESULTS FROM A PHASE 2 STUDY OF SOTATERCEPT ADMINISTERED INTRAVENOUSLY OR SUBCUTANEOUSLY FOR THE EVALUATION OF PHARMACOKINETICS, SAFETY, AND MAINTENANCE OF HEMOGLOBIN IN HEMODIALYSIS SUBJECTS

Frank Dellanna1, Kathleen Claes2, Idalécio Bernardo3, Nianhang Chen4, William T. Smith4, Hem Nalini Singh4, 1MVZ DaVita Karlstraße GmbH, Nephrology, Düsseldorf, GERMANY, 2Univ Hosps, Dept Nephrology, Leuven, BELGIUM, 3NephroCare Portimão, Dialysis Unit, Portimão, PORTUGAL, 4Celgene Corporation, Clinical Research & Development, Summit, NJ.

 

SO034

ASSOCIATION BETWEEN SERUM FERRITIN AND MORTALITY: US AND EURODOPPS FINDINGS

Angelo Karaboyas1, Jarcy Zee1, Hal Morgenstern2, Raymond Vanholder3, Stefan Jacobson4, Ronald Pisoni1, Friedrich Port1, Bruce Robinson1,5, 1Arbor Research Collaborative for Health, DOPPS, Ann Arbor, MI, 2Univ Michigan, Epidemiology, Ann Arbor, MI, 3Univ Hosp, Nephrology, Gent, BELGIUM, 4Karolinska Inst, Danderyd Hosp, Div Nephrology, Stockholm, SWEDEN, 5Univ Michigan, Internal Medicine, Ann Arbor, MI.

 

SO035

THE SAFETY OF INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM) IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD (ND-CKD): 1-YEAR RESULTS FROM THE FIND-CKD TRIAL

Simon Roger1, Andreas H. Bock2, Fernando Carrera3, Kai-Uwe Eckardt4, Carlo A. Gaillard5, David B. Van Wyck6, Yvonne Meier7, Sylvain Larroque7, Iain C. Macdougall8, 1Renal Research, Dept Nephrology, Gosford, AUSTRALIA, 2Kantonsspital, Dept Nephrology, Aarau, SWITZERLAND, 3Eurodial, Dialysis Unit, Leiria, PORTUGAL, 4Univ Erlangen-Nuremberg, Dept Nephrology, Erlangen, GERMANY, 5Univ Groningen, Dept Nephrology, Groningen, NETHERLANDS, 6Davita Healthcare Partners, Clinical Support Services, Denver, CO, 7Vifor Pharma Ltd, Medical Dept, Glattbrugg, SWITZERLAND, 8King’s College Hosp, Dept Renal Medicine, London, UK.

 

SO036

MOLIDUSTAT INCREASES HAEMOGLOBIN IN ERYTHROPOIESIS STIMULATING AGENTS (ESA)- NAIVE ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS (CKD-ND)

Iain C. Macdougall1, Tadao Akizawa2, Jeffrey Berns3, Silvia Lentini4, Thomas Bernhardt5, 1King’s College Hosp, Renal Medicine, London, UK, 2Showa Univ School Medicine, Div Nephrology, Tokyo, JAPAN, 3Univ Pennsylvania, Nephrology, Philadelphia, PA, 4Bayer AG, HealthCare, Wuppertal, GERMANY, 5Bayer AG, HealthCare, Berlin, GERMANY.

 

SO037

ANEMIA PREVALENCE AND TREATMENT AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 3-5: DATA FROM THE CHRONIC KIDNEY DISEASE OUTCOMES AND PRACTICE PATTERNS STUDY (CKDOPPS)

Michelle M. Y. Wong1, Charlotte Tu1, Lindsay Zepel1, Christian Combe2,3, Antonio A. Lopes4, Roberto Pecoits-Filho5, Ronald L. Pisoni1, Friedrich K. Port1, Helmut Reichel6, Bruce M. Robinson1, Ziad A. Massy7,8, on behalf of CKDopps and CKD REIN investigators, 1Arbor Research Collaborative for Health, DOPPS Program, Ann Arbor, MI, 2Centre Hosp Univ Bordeaux, Dept Nephrology Transplantation Dialysis, Bordeaux, FRANCE, 3Univ Bordeaux, Inserm U1026, Bordeaux, FRANCE, 4Federal Univ Bahia, Dept Medicine, Salvador, BRAZIL, 5Pontifícia Univ Católica do Paraná, School Medicine, Curitiba, BRAZIL, 6Nephrological Center Villingen-Schwenningen, Nephrology, Villingen-Schwenningen, GERMANY, 7Ambroise Paré Univ Hosp, Nephrology, APHP, Paris, FRANCE, 8CESP, UVSQ, Inserm U1018, Villejuif, FRANCE.

 

SO038

NEW NICE GUIDANCE: TESTS FOR IRON DEFICIENCY - FRIEND OR FOE?

C Brown, K Brown, D Jackson, B Jones, T Scale, R Ashcroft, O Brooks, A Mikhail, ABM Univ Health Board, Renal Dept, Swansea, UK.

 

back to timetable

 

 

 

 

 

 

 

final programme "day by day" - may 21 - 24, 2016

today